Literature DB >> 11606372

E1A inhibition of radiation-induced NF-kappaB activity through suppression of IKK activity and IkappaB degradation, independent of Akt activation.

R Shao1, E M Tsai, K Wei, R von Lindern, Y H Chen, K Makino, M C Hung.   

Abstract

Activation of the transcription factor nuclear factor kappaB (NF-kappaB) has been implicated in the protection of cells from apoptosis. We have shown previously that the adenovirus type 5 E1A sensitizes cells to radiation-induced apoptosis by inhibiting NF-kappaB activity. However, the exact mechanism of inhibition is not known. In this study, we compared the activity of inhibitor of nuclear factor-kappaB (IkappaB) kinase (IKK) and the degradation of IkappaBalpha in E1A transfectants and parental human cancer cells after ionizing radiation treatment. We found that radiation-induced IKK activity and IkappaBalpha degradation were inhibited in the E1A transfectants. Recently, Akt has been implicated in NF-kappaB activation. To test whether Akt is regulated by E1A and is involved in radiation-induced NF-kappaB activity, we examined the phosphorylation status of Akt in the E1A transfectants and parental cells and in irradiated cells. The results indicated that radiation induced Akt phosphorylation and that E1A inhibited basal but not radiation-induced Akt phosphorylation. We additionally examined radiation-induced NF-kappaB activity in cells stably transfected with a dominant-negative, inactive Akt and in parental cancer cells treated with a phosphatidylinositol 3-kinase inhibitor, wortmannin. We found that dominant-negative Akt and wortmannin did not block radiation-induced NF-kappaB activity. Thus, our results suggest that inhibition of IKK activity and IkappaB degradation is the predominant mechanism for E1A-mediated inhibition of radiation-induced NF-kappaB activity and that radiation-induced Akt activation cannot be inhibited by E1A and is likely independent of radiation-induced NF-kappaB activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11606372

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Radiation-induced activation of nuclear factor-kappaB involves selective degradation of plasma membrane-associated I(kappa)B(alpha).

Authors:  Jeffery S Russell; Philip J Tofilon
Journal:  Mol Biol Cell       Date:  2002-10       Impact factor: 4.138

2.  The ORF61 Protein Encoded by Simian Varicella Virus and Varicella-Zoster Virus Inhibits NF-κB Signaling by Interfering with IκBα Degradation.

Authors:  Travis Whitmer; Daniel Malouli; Luke S Uebelhoer; Victor R DeFilippis; Klaus Früh; Marieke C Verweij
Journal:  J Virol       Date:  2015-06-17       Impact factor: 5.103

3.  Activation of NF-κB by human papillomavirus 16 E1 limits E1-dependent viral replication through degradation of E1.

Authors:  Tomomi Nakahara; Katsuyuki Tanaka; Shin-ichi Ohno; Nagayasu Egawa; Takashi Yugawa; Tohru Kiyono
Journal:  J Virol       Date:  2015-02-25       Impact factor: 5.103

4.  E1A oncogene expression inhibits PTHrP P3 promoter activity and sensitizes human prostate cancer cells to TNF-induced apoptosis.

Authors:  Farrokh K Asadi; Subhash C Kukreja; Brigitte Boyer; Ana-Maria Valess; James L Cook
Journal:  Int Urol Nephrol       Date:  2010-01-16       Impact factor: 2.370

5.  E1a promotes c-Myc-dependent replicative stress: implications in glioblastoma radiosensitization.

Authors:  María Llanos Valero; Francisco Jose Cimas; Laura Arias; Pedro Melgar-Rojas; Elena García; Juan Luis Callejas-Valera; Jesús García-Cano; Leticia Serrano-Oviedo; Miguel Ángel de la Cruz-Morcillo; Isabel Sánchez-Pérez; Ricardo Sánchez-Prieto
Journal:  Cell Cycle       Date:  2013-10-11       Impact factor: 4.534

Review 6.  Advances in targeting IKK and IKK-related kinases for cancer therapy.

Authors:  Dung-Fang Lee; Mien-Chie Hung
Journal:  Clin Cancer Res       Date:  2008-09-15       Impact factor: 12.531

7.  Role of the E1A Rb-binding domain in repression of the NF-kappa B-dependent defense against tumor necrosis factor-alpha.

Authors:  James L Cook; Thomas A Walker; G Scott Worthen; Jay R Radke
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-15       Impact factor: 11.205

Review 8.  Targeting IκappaB kinases for cancer therapy.

Authors:  Nikee Awasthee; Vipin Rai; Srinivas Chava; Palanisamy Nallasamy; Ajaikumar B Kunnumakkara; Anupam Bishayee; Subhash C Chauhan; Kishore B Challagundla; Subash C Gupta
Journal:  Semin Cancer Biol       Date:  2018-02-24       Impact factor: 15.707

9.  Genistein suppresses tumor necrosis factor α-induced inflammation via modulating reactive oxygen species/Akt/nuclear factor κB and adenosine monophosphate-activated protein kinase signal pathways in human synoviocyte MH7A cells.

Authors:  Jinchao Li; Jun Li; Ye Yue; Yiping Hu; Wenxiang Cheng; Ruoxi Liu; Xiaohua Pan; Peng Zhang
Journal:  Drug Des Devel Ther       Date:  2014-03-17       Impact factor: 4.162

10.  Inhibitory effects of vinpocetine on the progression of atherosclerosis are mediated by Akt/NF-κB dependent mechanisms in apoE-/- mice.

Authors:  Jianhui Zhuang; Wenhui Peng; Hailing Li; Yuyan Lu; Ke Wang; Fan Fan; Shuang Li; Yawei Xu
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.